This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 1998 Apr;34(5):606-8.

doi: 10.1016/s0959-8049(98)00040-9.

Chemotherapy is antihormonal therapy--how much proof do oncologists need?

PMID: 9713262
DOI: 10.1016/s0959-8049(98)00040-9

Editorial

Chemotherapy is antihormonal therapy--how much proof do oncologists need?

V C Jordan. Eur J Cancer. 1998 Apr.

. 1998 Apr;34(5):606-8.

doi: 10.1016/s0959-8049(98)00040-9.

Author

PMID: 9713262
DOI: 10.1016/s0959-8049(98)00040-9

No abstract available

PubMed Disclaimer

Comment on

Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the International Breast Cancer Study Group (IBCSG) Trial VI.
Pagani O, O'Neill A, Castiglione M, Gelber RD, Goldhirsch A, Rudenstam CM, Lindtner J, Collins J, Crivellari D, Coates A, Cavalli F, Thürlimann B, Simoncini E, Fey M, Price K, Senn HJ. Pagani O, et al. Eur J Cancer. 1998 Apr;34(5):632-40. doi: 10.1016/s0959-8049(97)10036-3. Eur J Cancer. 1998. PMID: 9713266 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information